获英伟达支持的Iambic Therapeutics在完成1.5亿美元IPO后,上市首日股价大涨

路透中文
Oct 16
BUZZ-获英伟达支持的<a href="https://laohu8.com/S/IAM">Iambic Therapeutics</a>在完成1.5亿美元IPO后,上市首日股价大涨

10月15日 - ** Iambic Therapeutics(IAM.O)在完成1.5亿美元美国首次公开募股(IPO)后,纳斯达克首日上市股价大涨19%,涨至19.08美元

** 这家由Nvidia(辉达/英伟达)支持的药物研发公司股价开盘报每股16.15美元,高于16美元的IPO发行价

** 总部位于加利福尼亚州圣地亚哥的IAM售出 (link) 938万股,发行价在每股15至17美元的区间内 (link)

** 在整体IPO市场波动不定的背景下,生物科技领域依然是一大亮点

** “目前来看,这更像是一个小颠簸,而非三车连环相撞……我们以前也见过类似的回调”——文艺复兴资本高级策略师肯尼迪(Matt Kennedy)

** Iambic正利用其人工智能平台 (link) 推进一系列候选药物研发,用于治疗实体瘤

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10